APA (7th ed.) Citation

Merz, P., Ballikaya, S., Auffarth, G. U., & Schmack, I. (2018). Effects of ranibizumab (Lucentis®) and bevacizumab (Avastin®) on human corneal endothelial cells. BMC ophthalmology, 18, . https://doi.org/10.1186/s12886-018-0978-9

Chicago Style (17th ed.) Citation

Merz, Patrick, Seda Ballikaya, Gerd U. Auffarth, and Ingo Schmack. "Effects of Ranibizumab (Lucentis®) and Bevacizumab (Avastin®) on Human Corneal Endothelial Cells." BMC Ophthalmology 18 (2018). https://doi.org/10.1186/s12886-018-0978-9.

MLA (9th ed.) Citation

Merz, Patrick, et al. "Effects of Ranibizumab (Lucentis®) and Bevacizumab (Avastin®) on Human Corneal Endothelial Cells." BMC Ophthalmology, vol. 18, 2018, https://doi.org/10.1186/s12886-018-0978-9.